Bio-Reference Laboratories

OPKO Health to acquire Bio-Reference Laboratories for $1.5B

Friday, June 5, 2015

Opko Health, a multinational biopharmaceutical and diagnostics company, has signed a merger agreement to acquire Bio-Reference Laboratories, a Warwick, R.I.-based full service diagnostic laboratory. Bio-Reference Laboratories common stock holders will receive 2.75 shares of Opko common stock for each share of Bio-Reference common stock. Based on a closing price of $19.12 per share of Opko common stock on June 3, the transaction is valued at approximately $1.47 billion, or $52.58 per share of Bio-Reference common stock.

[Read More]